Ho Seok Kwon

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Samjin Pharmaceutical Co., Ltd., Astech. Co., Ltd., Bamichem Co., Ltd.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ho Seok Kwon. Retrieved from https://idiyas.com/inventor/ho-seok-kwon-3u3dqdzi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 4 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 3.2

ph-index = 1

Company Filing History:

2 out of 13

Samjin Pharmaceutical Co., Ltd.

Incheon National University Research & Business Foundation

patents

6. 1 out of 22

Incheon University Industry Academic Cooperation Foundation

patents

7. 1 out of 1

Samjin Pharmaceutical Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 2020-2026

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590070 - Adamantane derivatives as inhibitors of focal adhesion kinase (2026-03-31),

2. D1049217 - Typeface (2024-10-29),

3. 11420963 - Rebamipide prodrugs, preparation method and use thereof (2022-08-23),

4. 10844062 - Pyridine derivative inhibiting RAF kinase and vascular endothelial growth factor receptor, method for preparing same, pharmaceutical composition containing same, and use thereof (2020-11-24),

Title: The Innovative Contributions of Ho Seok Kwon

Introduction

Ho Seok Kwon is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of three patents to his name, Kwon has demonstrated a commitment to advancing medical science and improving patient care.

Latest Patents

One of Kwon's latest patents is focused on a novel rebamipide prodrug. This patent outlines a preparation method and the use of the prodrug, which has shown to increase the absorption rate by 25-fold compared to rebamipide itself. The pharmaceutical composition derived from this prodrug can be applied to the prophylaxis or therapy of various conditions, including gastric ulcers, acute gastritis, chronic gastritis, xerophthalmia, cancer, osteoarthritis, rheumatoid arthritis, and obesity. This innovation highlights Kwon's dedication to enhancing drug efficacy and patient outcomes.

Career Highlights

Throughout his career, Ho Seok Kwon has worked with reputable companies such as Samjin Pharmaceutical Co., Ltd. and Astech Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of pharmaceutical technologies.

Collaborations

Kwon has collaborated with esteemed colleagues, including Eui Hwan Cho and Hee Jong Shin. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical industry.

Conclusion

Ho Seok Kwon's contributions to the field of pharmaceuticals through his innovative patents and collaborations underscore his importance as an inventor. His work not only enhances drug formulations but also aims to improve the quality of life for patients suffering from various medical conditions.

Profile summary based on public USPTO records.